国际眼科纵览 ›› 2026, Vol. 50 ›› Issue (2): 141-147.doi: 10.3760/cma.j.cn115500-20251009-26210

• • 上一篇    下一篇

乳酸化修饰在糖尿病微血管并发症中的作用

马晨晨 陈月芹 解正高   

  1. 南京大学医学院附属鼓楼医院眼科,南京 210008
  • 收稿日期:2025-10-09 出版日期:2026-04-22 发布日期:2026-04-22
  • 通讯作者: 解正高,Email:zgxie87@163.com
  • 基金资助:
    国家自然科学基金(82501303);江苏省自然科学基基金(BK20240245、BK20251719)

The role of lactylation in the diabetic microvascular complications

Ma Chenchen, Chen Yueqin, Xie Zhenggao   

  1. Department of Ophthalmology Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing 210008, China
  • Received:2025-10-09 Online:2026-04-22 Published:2026-04-22
  • Contact: Xie Zhenggao, Email: zgxie87@163.com
  • Supported by:
    National Natural Science Foundation of China (82501303); Jiangsu Provincial Natural Science Foundation(BK20240245、BK20251719)

摘要: 乳酸化修饰是一种近年来新发现的蛋白质翻译后修饰,在基因表达、细胞代谢及多种疾病发生发展中发挥关键作用。然而,在糖尿病微血管并发症领域,其机制研究与临床转化仍处于深入探索阶段。本文综述了乳酸化修饰的调控机制,系统阐述其在糖尿病肾病、糖尿病视网膜病变及糖尿病周围神经病变中的作用,并展望了多学科交叉背景下生物标志物与靶向治疗的转化前景,旨在为糖尿病微血管并发症的防治及药物研发提供理论参考。

关键词: 乳酸化修饰, 糖尿病肾病, 糖尿病视网膜病变, 糖尿病周围神经病变

Abstract: Lysine lactylation (Kla) is a recently identified post-translational protein modification that plays a critical role in gene expression, cellular metabolism, and the pathogenesis of various diseases. However, research into the mechanisms and clinical translation of Kla in diabetic microvascular complications is still at an early stage of in-depth investigation. This review summarizes the regulatory mechanisms underlying lactylation, systematically describes the current progress of lactylation in diabetic nephropathy, diabetic retinopathy, and diabetic peripheral neuropathy, and explores the multidisciplinary translational potential of biomarkers and targeted therapies. It aims to provide a theoretical foundation for the prevention, treatment, and drug development of diabetic microvascular complications.


Key words: Lactylation, Diabetic nephropathy, Diabetic retinopathy, Diabetic peripheral neuropathy